Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?-Reference-Cited by-同舟云学术

Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?

Published:2005-06 Issue:9 Volume:95 Page:1219-1225
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Bollmann Magdolna,Heller Hildegard,Bankfalvi Agnes,Griefingholt Harald,Bollmann Reinhard

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2005.05509.x/fullpdf

Reference30 articles.

1. Superficial Bladder Cancer: Progression and Recurrence

2. Natural history of early bladder cancer

3. CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?

4. CYTOLOGIC AND HISTOLOGIC FEATURES OF SUPERFICIAL BLADDER CANCER

5. Evaluation of thin-layer methods in urine cytology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis;Diagnostics;2022-08-19

2. Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test;Frontiers in Genetics;2022-06-06

3. Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis;American Journal of Clinical Pathology;2021-06-04

4. Advances in urinary biomarker discovery in urological research;Investigative and Clinical Urology;2020

5. Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer;American Journal of Clinical Pathology;2019-11-16